id	sid	eid	entity	type
ajlm-2099	1	1	alshymaa a. ahmed department	PERSON
ajlm-2099	1	2	zagazig university	ORG
ajlm-2099	1	3	zagazig city	GPE
ajlm-2099	1	4	egypt	GPE
ajlm-2099	1	5	a. el shahawy department of medical microbiology	ORG
ajlm-2099	1	6	zagazig university	ORG
ajlm-2099	1	7	zagazig city	GPE
ajlm-2099	1	8	egypt	GPE
ajlm-2099	1	9	heba m. kadry department	PERSON
ajlm-2099	1	10	zagazig university	ORG
ajlm-2099	1	11	zagazig city	GPE
ajlm-2099	1	12	egypt	GPE
ajlm-2099	1	13	nora m.	PERSON
ajlm-2099	1	14	zagazig university	ORG
ajlm-2099	1	15	zagazig city	GPE
ajlm-2099	1	16	egypt	GPE
ajlm-2099	1	17	ahmed aa	PERSON
ajlm-2099	1	18	el shahawy aa	ORG
ajlm-2099	2	1	two	CARDINAL
ajlm-2099	2	2	multiplex	NORP
ajlm-2099	2	3	egyptian	NORP
ajlm-2099	3	1	afr j	PERSON
ajlm-2099	4	1	2023;12(1	CARDINAL
ajlm-2099	4	2	1	CARDINAL
ajlm-2099	4	3	two	CARDINAL
ajlm-2099	4	4	multiplex	NORP
ajlm-2099	4	5	egyptian	NORP
ajlm-2099	4	6	alshymaa a. ahmed	PERSON
ajlm-2099	4	7	a. el shahawy	PERSON
ajlm-2099	4	8	heba m. kadry	PERSON
ajlm-2099	4	9	nora m.	PERSON
ajlm-2099	4	10	14 oct. 2022	DATE
ajlm-2099	4	11	22	CARDINAL
ajlm-2099	4	12	2023	CARDINAL
ajlm-2099	4	13	18	CARDINAL
ajlm-2099	4	14	2023	CARDINAL
ajlm-2099	4	15	2023	CARDINAL
ajlm-2099	9	1	two	CARDINAL
ajlm-2099	10	1	105	CARDINAL
ajlm-2099	10	2	35	CARDINAL
ajlm-2099	10	3	30	CARDINAL
ajlm-2099	10	4	zagazig university	ORG
ajlm-2099	10	5	zagazig city	GPE
ajlm-2099	10	6	al sharqia governorate	ORG
ajlm-2099	10	7	athena multi-lyte	ORG
ajlm-2099	10	8	between may 2020	DATE
ajlm-2099	10	9	april 2022	DATE
ajlm-2099	11	1	seventy-five	CARDINAL
ajlm-2099	11	2	aiv	ORG
ajlm-2099	11	3	25	CARDINAL
ajlm-2099	11	4	3	CARDINAL
ajlm-2099	11	5	iif	ORG
ajlm-2099	11	6	athena multi-lyte	ORG
ajlm-2099	11	7	aiv system	PERSON
ajlm-2099	12	1	98.5%	PERCENT
ajlm-2099	12	2	96.9%	PERCENT
ajlm-2099	12	3	38.1%	PERCENT
ajlm-2099	13	1	47.6%	PERCENT
ajlm-2099	13	2	134	CARDINAL
ajlm-2099	13	3	100%	PERCENT
ajlm-2099	14	1	athena multi	ORG
ajlm-2099	14	2	aiv	ORG
ajlm-2099	14	3	iif	ORG
ajlm-2099	14	4	0.65	CARDINAL
ajlm-2099	14	5	0.85	CARDINAL
ajlm-2099	15	1	athena multi-lyte	ORG
ajlm-2099	15	2	aiv system	PERSON
ajlm-2099	15	3	iif	ORG
ajlm-2099	15	4	1	CARDINAL
ajlm-2099	15	5	3	CARDINAL
ajlm-2099	15	6	0.63	CARDINAL
ajlm-2099	16	1	athena multi-lyte	PERSON
ajlm-2099	16	2	3	CARDINAL
ajlm-2099	18	1	athena multi-lyte®	ORG
ajlm-2099	18	2	3	CARDINAL
ajlm-2099	20	1	multiplex	NORP
ajlm-2099	22	1	0.3	CARDINAL
ajlm-2099	22	2	100 000	CARDINAL
ajlm-2099	22	3	ukraine	GPE
ajlm-2099	22	4	31.5	CARDINAL
ajlm-2099	22	5	100 000	CARDINAL
ajlm-2099	22	6	the united kingdom.2	FAC
ajlm-2099	22	7	egypt	GPE
ajlm-2099	22	8	6.1	CARDINAL
ajlm-2099	22	9	100 000	QUANTITY
ajlm-2099	22	10	11.3	CARDINAL
ajlm-2099	22	11	100 000	QUANTITY
ajlm-2099	22	12	women.3	GPE
ajlm-2099	23	1	between 48	CARDINAL
ajlm-2099	23	2	184	CARDINAL
ajlm-2099	23	3	million	CARDINAL
ajlm-2099	23	4	egypt	GPE
ajlm-2099	23	5	aav	ORG
ajlm-2099	23	6	about 3.6%	PERCENT
ajlm-2099	23	7	africa	LOC
ajlm-2099	24	1	the european league	ORG
ajlm-2099	24	2	the american college of rheumatology	ORG
ajlm-2099	24	3	1:80.10	CARDINAL
ajlm-2099	25	1	c3	PERSON
ajlm-2099	27	1	20% to 55%	PERCENT
ajlm-2099	27	2	60%	PERCENT
ajlm-2099	27	3	sle.15,16 multiplex bead	PERSON
ajlm-2099	28	1	one	CARDINAL
ajlm-2099	29	1	2019	CARDINAL
ajlm-2099	29	2	european league	ORG
ajlm-2099	29	3	the american college of rheumatology classification	ORG
ajlm-2099	31	1	three	CARDINAL
ajlm-2099	32	1	3-anca	QUANTITY
ajlm-2099	32	2	anca	PERSON
ajlm-2099	32	3	1999	DATE
ajlm-2099	32	4	anca detection.22	ORG
ajlm-2099	33	1	2017	CARDINAL
ajlm-2099	33	2	anca testing23	PERSON
ajlm-2099	34	1	iif confirmation.24,25	ORG
ajlm-2099	34	2	anca	PERSON
ajlm-2099	34	3	athena multi-lyte®	ORG
ajlm-2099	35	1	5926	DATE
ajlm-2099	36	1	younger than 18 years	DATE
ajlm-2099	38	1	zagazig university	ORG
ajlm-2099	38	2	zagazig	GPE
ajlm-2099	38	3	al sharqia	PERSON
ajlm-2099	38	4	egypt	GPE
ajlm-2099	38	5	may 2020 to	DATE
ajlm-2099	38	6	april 2022	DATE
ajlm-2099	40	1	3	CARDINAL
ajlm-2099	40	2	95%	PERCENT
ajlm-2099	40	3	90%	PERCENT
ajlm-2099	40	4	10%	PERCENT
ajlm-2099	40	5	33%	PERCENT
ajlm-2099	40	6	up to 3%	PERCENT
ajlm-2099	40	7	6%	PERCENT
ajlm-2099	40	8	46%	PERCENT
ajlm-2099	40	9	up to 6%	PERCENT
ajlm-2099	40	10	170	CARDINAL
ajlm-2099	40	11	105	CARDINAL
ajlm-2099	40	12	european league	ORG
ajlm-2099	40	13	the american college of rheumatology	ORG
ajlm-2099	40	14	classification18	ORG
ajlm-2099	40	15	65	CARDINAL
ajlm-2099	41	1	35	CARDINAL
ajlm-2099	41	2	30	CARDINAL
ajlm-2099	42	1	anca	ORG
ajlm-2099	42	2	75	CARDINAL
ajlm-2099	42	3	aiv	ORG
ajlm-2099	42	4	25	CARDINAL
ajlm-2099	46	1	6000	CARDINAL
ajlm-2099	46	2	roche	ORG
ajlm-2099	46	3	switzerland	GPE
ajlm-2099	47	1	3	CARDINAL
ajlm-2099	47	2	igg	ORG
ajlm-2099	47	3	lübeck	GPE
ajlm-2099	47	4	germany	GPE
ajlm-2099	47	5	anti-pm	TIME
ajlm-2099	48	1	two millilitres	QUANTITY
ajlm-2099	49	1	15 min –	TIME
ajlm-2099	49	2	30 min	TIME
ajlm-2099	49	3	1000−2000	CARDINAL
ajlm-2099	49	4	10 min	TIME
ajlm-2099	50	1	multiplex microbead	PERSON
ajlm-2099	50	2	athena multi	ORG
ajlm-2099	50	3	evans way	ORG
ajlm-2099	50	4	branchburg	GPE
ajlm-2099	50	5	new jersey	GPE
ajlm-2099	50	6	united states	GPE
ajlm-2099	50	7	eight	CARDINAL
ajlm-2099	50	8	sm	ORG
ajlm-2099	50	9	rnp	GPE
ajlm-2099	50	10	scl-70	GPE
ajlm-2099	51	1	athena multi	ORG
ajlm-2099	51	2	evans way	ORG
ajlm-2099	51	3	branchburg	GPE
ajlm-2099	51	4	new jersey	GPE
ajlm-2099	51	5	united states	GPE
ajlm-2099	51	6	three	CARDINAL
ajlm-2099	51	7	3	CARDINAL
ajlm-2099	52	1	120	CARDINAL
ajlm-2099	53	1	microsphere	PERSON
ajlm-2099	53	2	luminex200	ORG
ajlm-2099	53	3	austin	GPE
ajlm-2099	53	4	texas	GPE
ajlm-2099	53	5	united states	GPE
ajlm-2099	55	1	nova	LOC
ajlm-2099	55	2	dsdna c. luciliae kits	PERSON
ajlm-2099	55	3	inova diagnostics, inc.	ORG
ajlm-2099	55	4	san diego	GPE
ajlm-2099	55	5	california	GPE
ajlm-2099	55	6	united states	GPE
ajlm-2099	56	1	1/10	CARDINAL
ajlm-2099	56	2	1/20	CARDINAL
ajlm-2099	56	3	1/640	CARDINAL
ajlm-2099	57	1	nova	LOC
ajlm-2099	57	2	anca anti	PERSON
ajlm-2099	57	3	inova diagnostics, inc.	ORG
ajlm-2099	57	4	san diego	GPE
ajlm-2099	57	5	california	GPE
ajlm-2099	57	6	united states	GPE
ajlm-2099	58	1	1/20	CARDINAL
ajlm-2099	60	1	3	CARDINAL
ajlm-2099	60	2	3	CARDINAL
ajlm-2099	60	3	3	CARDINAL
ajlm-2099	60	4	gmbh	GPE
ajlm-2099	60	5	mainz	GPE
ajlm-2099	60	6	germany	GPE
ajlm-2099	60	7	3	CARDINAL
ajlm-2099	60	8	5	CARDINAL
ajlm-2099	63	1	spss	ORG
ajlm-2099	63	2	20.0	CARDINAL
ajlm-2099	63	3	ibm	ORG
ajlm-2099	63	4	armonk	GPE
ajlm-2099	63	5	new york	GPE
ajlm-2099	63	6	united states	GPE
ajlm-2099	65	1	cohen	PERSON
ajlm-2099	65	2	0.01–0.2	CARDINAL
ajlm-2099	65	3	0.21–0.4	CARDINAL
ajlm-2099	65	4	0.41–0.61	CARDINAL
ajlm-2099	65	5	0.61–0.8	CARDINAL
ajlm-2099	65	6	0.81–1	CARDINAL
ajlm-2099	66	1	95%	PERCENT
ajlm-2099	67	1	one	CARDINAL
ajlm-2099	68	1	athena multi-lyte®	ORG
ajlm-2099	68	2	ana-ii	PERSON
ajlm-2099	68	3	iif	ORG
ajlm-2099	68	4	0.05	CARDINAL
ajlm-2099	69	1	medcalc software ltd	ORG
ajlm-2099	69	2	acacialaan	GPE
ajlm-2099	70	1	105	CARDINAL
ajlm-2099	70	2	30	CARDINAL
ajlm-2099	70	3	35	CARDINAL
ajlm-2099	71	1	18	CARDINAL
ajlm-2099	71	2	15	CARDINAL
ajlm-2099	72	1	the anca group	ORG
ajlm-2099	72	2	75	CARDINAL
ajlm-2099	72	3	aiv	ORG
ajlm-2099	72	4	25	CARDINAL
ajlm-2099	73	1	5 to 60 years	DATE
ajlm-2099	73	2	±	CARDINAL
ajlm-2099	73	3	32.4 ±	CARDINAL
ajlm-2099	73	4	12.8 years	DATE
ajlm-2099	73	5	80	DATE
ajlm-2099	73	6	76.1%	PERCENT
ajlm-2099	73	7	1	CARDINAL
ajlm-2099	74	1	aiv	ORG
ajlm-2099	74	2	14 to 77 years	DATE
ajlm-2099	74	3	±	CARDINAL
ajlm-2099	74	4	38.4 ±	CARDINAL
ajlm-2099	74	5	15.7 years	DATE
ajlm-2099	74	6	50	CARDINAL
ajlm-2099	74	7	66.7%	PERCENT
ajlm-2099	75	1	1	CARDINAL
ajlm-2099	75	2	the zagazig university	ORG
ajlm-2099	75	3	zagazig	GPE
ajlm-2099	75	4	al sharqia	PERSON
ajlm-2099	75	5	egypt	GPE
ajlm-2099	75	6	may 2020	DATE
ajlm-2099	75	7	april 2022	DATE
ajlm-2099	76	1	86.7%	PERCENT
ajlm-2099	76	2	2	CARDINAL
ajlm-2099	77	1	82.8%	PERCENT
ajlm-2099	77	2	87/105	CARDINAL
ajlm-2099	77	3	75.2%	PERCENT
ajlm-2099	78	1	80.0%	PERCENT
ajlm-2099	78	2	60/75	CARDINAL
ajlm-2099	78	3	57.3%	PERCENT
ajlm-2099	78	4	43/75	CARDINAL
ajlm-2099	79	1	66.7%	PERCENT
ajlm-2099	79	2	50/75	CARDINAL
ajlm-2099	79	3	56.0%	PERCENT
ajlm-2099	79	4	42/75	CARDINAL
ajlm-2099	80	1	100%	PERCENT
ajlm-2099	80	2	105/105	DATE
ajlm-2099	80	3	77.1%	PERCENT
ajlm-2099	80	4	27/35	CARDINAL
ajlm-2099	82	1	2	CARDINAL
ajlm-2099	82	2	zagazig university	ORG
ajlm-2099	82	3	zagazig	GPE
ajlm-2099	82	4	al sharqia	PERSON
ajlm-2099	82	5	egypt	GPE
ajlm-2099	82	6	may 2020	DATE
ajlm-2099	82	7	april 2022	DATE
ajlm-2099	83	1	iif	ORG
ajlm-2099	83	2	athena multi-lyte ana-ii	ORG
ajlm-2099	83	3	38.1%	PERCENT
ajlm-2099	83	4	iif	ORG
ajlm-2099	83	5	athena multi-lyte®	ORG
ajlm-2099	83	6	ana-ii	PERSON
ajlm-2099	84	1	athena multi-lyte®	ORG
ajlm-2099	84	2	ana-ii	PERSON
ajlm-2099	84	3	9.5%	PERCENT
ajlm-2099	84	4	100	CARDINAL
ajlm-2099	84	5	120	CARDINAL
ajlm-2099	85	1	iif	ORG
ajlm-2099	85	2	athena multi-lyte®	ORG
ajlm-2099	85	3	ana-ii	PERSON
ajlm-2099	86	1	one	CARDINAL
ajlm-2099	86	2	iif	ORG
ajlm-2099	87	1	athena multi-lyte ana-ii	ORG
ajlm-2099	87	2	0.55	CARDINAL
ajlm-2099	87	3	0.001	CARDINAL
ajlm-2099	88	1	athena multi-lyte	ORG
ajlm-2099	88	2	ana-ii	PERSON
ajlm-2099	88	3	iif	ORG
ajlm-2099	88	4	0.66	CARDINAL
ajlm-2099	88	5	95%	PERCENT
ajlm-2099	88	6	0.53–0.79, percent	PERCENT
ajlm-2099	88	7	87.6%	PERCENT
ajlm-2099	88	8	0.001	CARDINAL
ajlm-2099	89	1	120	CARDINAL
ajlm-2099	89	2	athena multi-lyte ana-ii	ORG
ajlm-2099	89	3	38.1%	PERCENT
ajlm-2099	89	4	98.5%	PERCENT
ajlm-2099	89	5	1	CARDINAL
ajlm-2099	89	6	1	CARDINAL
ajlm-2099	90	1	109	CARDINAL
ajlm-2099	90	2	46.7%	PERCENT
ajlm-2099	90	3	96.9%	PERCENT
ajlm-2099	91	1	100%	PERCENT
ajlm-2099	91	2	134	CARDINAL
ajlm-2099	91	3	37.1%	PERCENT
ajlm-2099	92	1	iif	ORG
ajlm-2099	92	2	38.1%	PERCENT
ajlm-2099	92	3	96.9%	PERCENT
ajlm-2099	93	1	120	CARDINAL
ajlm-2099	93	2	47.6%	PERCENT
ajlm-2099	93	3	96.9%	PERCENT
ajlm-2099	94	1	1	CARDINAL
ajlm-2099	94	2	iif	ORG
ajlm-2099	94	3	athena multi-lyte ana-ii	ORG
ajlm-2099	94	4	zagazig university	ORG
ajlm-2099	94	5	zagazig	GPE
ajlm-2099	94	6	al sharqia	PERSON
ajlm-2099	94	7	egypt	GPE
ajlm-2099	94	8	between may 2020	DATE
ajlm-2099	94	9	april 2022	DATE
ajlm-2099	95	1	the european league	ORG
ajlm-2099	95	2	the american college of rheumatology criteria	ORG
ajlm-2099	96	1	athena multi-lyte®	ORG
ajlm-2099	96	2	ana-ii	PERSON
ajlm-2099	96	3	iif	ORG
ajlm-2099	97	1	athena multi-lyte®	ORG
ajlm-2099	97	2	ana-ii	PERSON
ajlm-2099	97	3	73.8%	PERCENT
ajlm-2099	97	4	95%	PERCENT
ajlm-2099	97	5	57.96%	PERCENT
ajlm-2099	97	6	86.14%	PERCENT
ajlm-2099	97	7	92.19%	PERCENT
ajlm-2099	97	8	86.10%	PERCENT
ajlm-2099	97	9	96.19%	PERCENT
ajlm-2099	97	10	75.61%	PERCENT
ajlm-2099	97	11	62.47%	PERCENT
ajlm-2099	97	12	85.24%	PERCENT
ajlm-2099	97	13	91.47%	PERCENT
ajlm-2099	97	14	86.56%	PERCENT
ajlm-2099	97	15	94.70%	PERCENT
ajlm-2099	97	16	87.65%	PERCENT
ajlm-2099	97	17	81.74%	PERCENT
ajlm-2099	97	18	92.19%	PERCENT
ajlm-2099	97	19	0.830	CARDINAL
ajlm-2099	97	20	0.746–0.914	ORDINAL
ajlm-2099	97	21	2	CARDINAL
ajlm-2099	98	1	2	CARDINAL
ajlm-2099	98	2	athena multi-lyte ana-ii	ORG
ajlm-2099	98	3	zagazig	GPE
ajlm-2099	98	4	al sharqia	PERSON
ajlm-2099	98	5	egypt	GPE
ajlm-2099	98	6	between may 2020	DATE
ajlm-2099	98	7	april 2022	DATE
ajlm-2099	100	1	3	CARDINAL
ajlm-2099	100	2	iif	ORG
ajlm-2099	100	3	athena multi-lyte®	ORG
ajlm-2099	100	4	iif	ORG
ajlm-2099	100	5	62.7%	PERCENT
ajlm-2099	100	6	47/75	CARDINAL
ajlm-2099	100	7	14.7%	PERCENT
ajlm-2099	100	8	11/75	CARDINAL
ajlm-2099	100	9	p-anca	ORG
ajlm-2099	100	10	c-anca	PERSON
ajlm-2099	100	11	iif	ORG
ajlm-2099	100	12	only 40.0%	PERCENT
ajlm-2099	100	13	30/75	CARDINAL
ajlm-2099	100	14	14.7%	PERCENT
ajlm-2099	100	15	11/75	CARDINAL
ajlm-2099	100	16	3	CARDINAL
ajlm-2099	100	17	athena multi-lyte aiv	ORG
ajlm-2099	101	1	32.0%	PERCENT
ajlm-2099	101	2	24/75	CARDINAL
ajlm-2099	101	3	28.0%	PERCENT
ajlm-2099	101	4	21/75	CARDINAL
ajlm-2099	101	5	3	CARDINAL
ajlm-2099	102	1	3	CARDINAL
ajlm-2099	102	2	three	CARDINAL
ajlm-2099	104	1	iif	ORG
ajlm-2099	104	2	athena multi-lyte aiv	ORG
ajlm-2099	104	3	0.653	CARDINAL
ajlm-2099	104	4	iif	ORG
ajlm-2099	104	5	0.525	MONEY
ajlm-2099	104	6	athena multi-lyte aiv	ORG
ajlm-2099	104	7	3	CARDINAL
ajlm-2099	105	1	3	CARDINAL
ajlm-2099	105	2	athena multi-lyte aiv	ORG
ajlm-2099	105	3	iif	ORG
ajlm-2099	105	4	1	CARDINAL
ajlm-2099	105	5	iif	ORG
ajlm-2099	105	6	athena multi-lyte aiv	ORG
ajlm-2099	105	7	0.635	CARDINAL
ajlm-2099	106	1	athena multi	ORG
ajlm-2099	106	2	0.606	CARDINAL
ajlm-2099	106	3	0.001	CARDINAL
ajlm-2099	106	4	3	CARDINAL
ajlm-2099	106	5	0.363	CARDINAL
ajlm-2099	106	6	0.006	CARDINAL
ajlm-2099	107	1	3	CARDINAL
ajlm-2099	107	2	athena multi-lyte aiv	ORG
ajlm-2099	107	3	iif	ORG
ajlm-2099	107	4	anca	PERSON
ajlm-2099	107	5	aiv	ORG
ajlm-2099	107	6	zagazig university	ORG
ajlm-2099	107	7	zagazig	GPE
ajlm-2099	107	8	al sharqia	PERSON
ajlm-2099	107	9	egypt	GPE
ajlm-2099	107	10	between may 2020	DATE
ajlm-2099	107	11	april 2022	DATE
ajlm-2099	108	1	3	CARDINAL
ajlm-2099	108	2	aiv	ORG
ajlm-2099	109	1	athena multi-lyte aiv	ORG
ajlm-2099	109	2	iif	ORG
ajlm-2099	110	1	athena multi-lyte aiv	ORG
ajlm-2099	110	2	63.8%	PERCENT
ajlm-2099	110	3	51.6%	PERCENT
ajlm-2099	110	4	100%	PERCENT
ajlm-2099	110	5	2	CARDINAL
ajlm-2099	111	1	3	CARDINAL
ajlm-2099	111	2	100%	PERCENT
ajlm-2099	111	3	athena multi-lyte aiv	ORG
ajlm-2099	111	4	100%	PERCENT
ajlm-2099	111	5	88.8%	PERCENT
ajlm-2099	112	1	iif	ORG
ajlm-2099	112	2	240.00 egyptian pounds	MONEY
ajlm-2099	113	1	egp	ORG
ajlm-2099	113	2	iif	ORG
ajlm-2099	113	3	4	CARDINAL
ajlm-2099	114	1	anca	PERSON
ajlm-2099	114	2	200.00	CARDINAL
ajlm-2099	114	3	egp	ORG
ajlm-2099	114	4	180 min	QUANTITY
ajlm-2099	114	5	two	CARDINAL
ajlm-2099	114	6	3	CARDINAL
ajlm-2099	115	1	athena multi-lyte	ORG
ajlm-2099	115	2	90 min	TIME
ajlm-2099	115	3	120.00	CARDINAL
ajlm-2099	115	4	egp	ORG
ajlm-2099	116	1	4	CARDINAL
ajlm-2099	116	2	athena multi-lyte	ORG
ajlm-2099	116	3	iif	ORG
ajlm-2099	116	4	anca	PERSON
ajlm-2099	116	5	aiv	ORG
ajlm-2099	116	6	zagazig university	ORG
ajlm-2099	116	7	zagazig	GPE
ajlm-2099	116	8	al sharqia	PERSON
ajlm-2099	116	9	egypt	GPE
ajlm-2099	116	10	between may 2020	DATE
ajlm-2099	116	11	april 2022	DATE
ajlm-2099	117	1	two	CARDINAL
ajlm-2099	117	2	multiplex bead	ORG
ajlm-2099	117	3	athena multi	ORG
ajlm-2099	117	4	athena multi-lyte aiv	PERSON
ajlm-2099	117	5	ancas	GPE
ajlm-2099	118	1	multiplex	NORP
ajlm-2099	119	1	athena multi	ORG
ajlm-2099	120	1	athena multi-lyte	ORG
ajlm-2099	121	1	canada	GPE
ajlm-2099	121	2	201033	DATE
ajlm-2099	121	3	2013,34	DATE
ajlm-2099	121	4	italy	GPE
ajlm-2099	121	5	2018.15	CARDINAL
ajlm-2099	121	6	bio-rad	PERSON
ajlm-2099	121	7	hercules	GPE
ajlm-2099	121	8	california	GPE
ajlm-2099	121	9	united states	GPE
ajlm-2099	121	10	iif.	ORG
ajlm-2099	122	1	athena multi	ORG
ajlm-2099	123	1	47.6%	PERCENT
ajlm-2099	124	1	two	CARDINAL
ajlm-2099	124	2	italy	GPE
ajlm-2099	124	3	201514	DATE
ajlm-2099	124	4	201815	DATE
ajlm-2099	124	5	multiplex bead	ORG
ajlm-2099	124	6	specific.15	CARDINAL
ajlm-2099	124	7	athena multi	ORG
ajlm-2099	125	1	athena multi-lyte ana-ii	ORG
ajlm-2099	125	2	iif	ORG
ajlm-2099	126	1	multi-lyte	NORP
ajlm-2099	126	2	one	CARDINAL
ajlm-2099	127	1	athena multi	ORG
ajlm-2099	128	1	athena multi-lyte	ORG
ajlm-2099	128	2	iif for anti	ORG
ajlm-2099	128	3	3	CARDINAL
ajlm-2099	129	1	one	CARDINAL
ajlm-2099	129	2	netherlands	GPE
ajlm-2099	129	3	2007	DATE
ajlm-2099	129	4	2017	DATE
ajlm-2099	129	5	germany	GPE
ajlm-2099	129	6	denmark	GPE
ajlm-2099	129	7	netherlands	GPE
ajlm-2099	129	8	only one	CARDINAL
ajlm-2099	129	9	the united states	GPE
ajlm-2099	129	10	2018,37	CARDINAL
ajlm-2099	129	11	multiplex bead	ORG
ajlm-2099	129	12	0.35	CARDINAL
ajlm-2099	129	13	3	CARDINAL
ajlm-2099	129	14	0.53	CARDINAL
ajlm-2099	130	1	bio-plex	ORG
ajlm-2099	130	2	2200	CARDINAL
ajlm-2099	130	3	bio-rad	PERSON
ajlm-2099	130	4	hercules	GPE
ajlm-2099	130	5	california	GPE
ajlm-2099	130	6	united states	GPE
ajlm-2099	131	1	athena multi-lyte aiv	ORG
ajlm-2099	131	2	3	CARDINAL
ajlm-2099	132	1	athena multi-lyte aiv	ORG
ajlm-2099	133	1	3	CARDINAL
ajlm-2099	133	2	athena multi-lyte aiv	ORG
ajlm-2099	134	1	anca	PERSON
ajlm-2099	135	1	athena multi-lyte aiv	ORG
ajlm-2099	135	2	anca iif assays	PERSON
ajlm-2099	136	1	athena multi	ORG
ajlm-2099	136	2	3	CARDINAL
ajlm-2099	138	1	aiv	ORG
ajlm-2099	138	2	athena multi	ORG
ajlm-2099	140	1	multiplex	NORP
ajlm-2099	141	1	aiv	ORG
ajlm-2099	141	2	3	CARDINAL
ajlm-2099	144	1	a.a.e.s	GPE
ajlm-2099	149	1	a.a.e.s	GPE
ajlm-2099	155	1	kitching ar	PERSON
ajlm-2099	155	2	anders h-j	ORG
ajlm-2099	155	3	basu n	PERSON
ajlm-2099	155	4	anca	PERSON
ajlm-2099	156	1	nat rev dis	PERSON
ajlm-2099	157	1	2020;6(1):71	CARDINAL
ajlm-2099	158	1	carter ee	PERSON
ajlm-2099	158	2	barr sg	PERSON
ajlm-2099	158	3	clarke ae	PERSON
ajlm-2099	160	1	nat rev rheumatol	PERSON
ajlm-2099	161	1	2016;12(10):605–620.	CARDINAL
ajlm-2099	162	1	noor ra	PERSON
ajlm-2099	162	2	abualfadl e	PERSON
ajlm-2099	163	1	egypt	GPE
ajlm-2099	163	2	3661	CARDINAL
ajlm-2099	165	1	2021;30(9):1526–1535	CARDINAL
ajlm-2099	166	1	phillip r	PERSON
ajlm-2099	167	1	clin exp	ORG
ajlm-2099	168	1	2008;26(5	CARDINAL
ajlm-2099	168	2	51):s94	CARDINAL
ajlm-2099	168	3	attia dhs	PERSON
ajlm-2099	168	4	abdel noor ra	PERSON
ajlm-2099	168	5	salah s.	PERSON
ajlm-2099	168	6	egypt	GPE
ajlm-2099	169	1	clin	PERSON
ajlm-2099	170	1	2019;38(6):1675–1684	CARDINAL
ajlm-2099	171	1	shahin aa	PERSON
ajlm-2099	171	2	zayed hs	PERSON
ajlm-2099	171	3	elrefai rm	PERSON
ajlm-2099	172	1	egyptians	NORP
ajlm-2099	172	2	630	CARDINAL
ajlm-2099	173	1	egypt	GPE
ajlm-2099	174	1	2018;40(4):243–248	CARDINAL
ajlm-2099	174	2	mohammad aj	PERSON
ajlm-2099	174	3	gatenby p	PERSON
ajlm-2099	174	4	basu n	PERSON
ajlm-2099	174	5	antineutrophil	NORP
ajlm-2099	175	1	nephrol dial transplant	ORG
ajlm-2099	176	1	2015;30	CARDINAL
ajlm-2099	176	2	1	CARDINAL
ajlm-2099	176	3	i14	ORG
ajlm-2099	177	1	guthridge jm	PERSON
ajlm-2099	179	1	2012;64(11):3677–3686	CARDINAL
ajlm-2099	179	2	bunn c	ORG
ajlm-2099	179	3	swana g	PERSON
ajlm-2099	179	4	karim y.	PERSON
ajlm-2099	179	5	multiplex	NORP
ajlm-2099	179	6	anti-ena	NORP
ajlm-2099	182	1	https://doi.org/10.1016/j.jim.2010.12.010 yates m	PERSON
ajlm-2099	182	2	watts	LOC
ajlm-2099	182	3	bajema	PERSON
ajlm-2099	183	1	anca-associated	ORG
ajlm-2099	184	1	ann rheum dis	PERSON
ajlm-2099	186	1	https://doi.org/10.1136/annrheumdis-2016-209133 zhao j	PERSON
ajlm-2099	186	2	wang k	PERSON
ajlm-2099	186	3	wang x	PERSON
ajlm-2099	187	1	chinese	NORP
ajlm-2099	188	1	clin	PERSON
ajlm-2099	189	1	2018;37(1):139–144	CARDINAL
ajlm-2099	190	1	abuaf n	PERSON
ajlm-2099	192	1	j immunol	PERSON
ajlm-2099	193	1	2019;2019:6047085	CARDINAL
ajlm-2099	194	1	slater ng	PERSON
ajlm-2099	194	2	cameron	PERSON
ajlm-2099	196	1	clin	PERSON
ajlm-2099	197	1	1976;25(3):480–486	CARDINAL
ajlm-2099	197	2	infantino m	ORG
ajlm-2099	198	1	quanta	GPE
ajlm-2099	198	2	four	CARDINAL
ajlm-2099	199	1	j immunol	PERSON
ajlm-2099	200	1	2015;2015:902821	CARDINAL
ajlm-2099	201	1	https://doi.org/10.1155/2015/902821	ORG
ajlm-2099	201	2	manfredi m	ORG
ajlm-2099	203	1	immunol	PERSON
ajlm-2099	204	1	2018;66(3):340–347	CARDINAL
ajlm-2099	205	1	nat rev rheumatol	PERSON
ajlm-2099	206	1	2016;12(2):102–110	CARDINAL
ajlm-2099	207	1	enocsson	PERSON
ajlm-2099	208	1	four	CARDINAL
ajlm-2099	210	1	2015;42(5):817–825	CARDINAL
ajlm-2099	211	1	https://doi.org/10.3899/jrheum.140677 aringer m. eular	PERSON
ajlm-2099	214	1	https://doi.org/10.1016/j.semarthrit.2019.09.009	ORG
ajlm-2099	214	2	agmon-levin n	PERSON
ajlm-2099	214	3	damoiseaux j	PERSON
ajlm-2099	216	1	ann rheum dis	PERSON
ajlm-2099	217	1	2014;73(1):17–23	CARDINAL
ajlm-2099	218	1	https://doi.org/10.1136/annrheumdis-2013-203863	NORP
ajlm-2099	218	2	csernok e	PERSON
ajlm-2099	218	3	damoiseaux j	PERSON
ajlm-2099	219	1	autoimmun rev	PERSON
ajlm-2099	220	1	2016;15(7):736–741	CARDINAL
ajlm-2099	221	1	csernok e	PERSON
ajlm-2099	221	2	hellmich b. anti	PERSON
ajlm-2099	221	3	anca	PERSON
ajlm-2099	222	1	j immunol	PERSON
ajlm-2099	223	1	2018;456:1–6	CARDINAL
ajlm-2099	224	1	gillis	PERSON
ajlm-2099	224	2	benson e	PERSON
ajlm-2099	225	1	antineutrophil	NORP
ajlm-2099	226	1	j clin	PERSON
ajlm-2099	227	1	1999;111(4):507–513	DATE
ajlm-2099	228	1	https://doi.org/10.1093/ajcp/111.4.507 damoiseaux j	PERSON
ajlm-2099	228	2	rasmussen n	PERSON
ajlm-2099	228	3	antineutrophil	NORP
ajlm-2099	228	4	european	NORP
ajlm-2099	229	1	ann rheum dis	PERSON
ajlm-2099	230	1	2017;76(4):647–653	CARDINAL
ajlm-2099	230	2	https://doi.org/10.1136/annrheumdis-2016-209507	NORP
ajlm-2099	230	3	conrad k	PERSON
ajlm-2099	230	4	roggenbuck d	GPE
ajlm-2099	230	5	reinhold	GPE
ajlm-2099	231	1	autoimmun rev	PERSON
ajlm-2099	232	1	2012;11(3):207–211	CARDINAL
ajlm-2099	233	1	https://doi.org/10.1016/j.autrev.2011.05.014 sowa m	ORG
ajlm-2099	233	2	knutter	PERSON
ajlm-2099	234	1	plos one	PERSON
ajlm-2099	235	1	2014;9(9):e107743	CARDINAL
ajlm-2099	236	1	https://doi.org/10.1371/journal.pone.0107743 shrestha b	PERSON
ajlm-2099	236	2	dunn l.	PERSON
ajlm-2099	236	3	helsinki	ORG
ajlm-2099	236	4	seventh	ORDINAL
ajlm-2099	238	1	2020;17(4):548–552	CARDINAL
ajlm-2099	238	2	sullivan km	PERSON
ajlm-2099	239	1	soe mm	PERSON
ajlm-2099	240	1	2009;124(3):471–474	CARDINAL
ajlm-2099	241	1	waling mm	PERSON
ajlm-2099	241	2	adhin aa	PERSON
ajlm-2099	241	3	schreurs mwj	PERSON
ajlm-2099	242	1	anca-associated	ORG
ajlm-2099	243	1	autoimmun rev	PERSON
ajlm-2099	244	1	2021;20(1):102716	CARDINAL
ajlm-2099	245	1	wei	PERSON
ajlm-2099	245	2	jiang y	PERSON
ajlm-2099	245	3	xiao m	PERSON
ajlm-2099	246	1	scand j immunol	PERSON
ajlm-2099	248	1	https://doi.org/10.1111/sji.12849 mclaren	PERSON
ajlm-2099	248	2	stimson rh	PERSON
ajlm-2099	248	3	coia je	PERSON
ajlm-2099	251	1	2001;94(11):615–621	CARDINAL
ajlm-2099	253	1	anesth analg	PERSON
ajlm-2099	255	1	shah ia	PERSON
ajlm-2099	255	2	bhutto aub	PERSON
ajlm-2099	255	3	memon s.	PERSON
ajlm-2099	256	1	cureus	PERSON
ajlm-2099	257	1	2021;13(1):e12909	TIME
ajlm-2099	257	2	thompson k	PERSON
ajlm-2099	257	3	mccurdy g	PERSON
ajlm-2099	257	4	wilton k. measurement	PERSON
ajlm-2099	257	5	multiplex	ORG
ajlm-2099	258	1	j immunol	PERSON
ajlm-2099	259	1	2010;352(1–2):147–152	CARDINAL
ajlm-2099	260	1	https://doi.org/10.1016/j.jim.2009.10.003 venner aa	PERSON
ajlm-2099	260	2	three	CARDINAL
ajlm-2099	261	1	clin biochem	ORG
ajlm-2099	262	1	2013;46(4–5):317–320	CARDINAL
ajlm-2099	263	1	knapen	PERSON
ajlm-2099	264	1	multiplex	NORP
ajlm-2099	264	2	anca-associated	ORG
ajlm-2099	265	1	ann n y acad sci	PERSON
ajlm-2099	266	1	2007;1109(1):454–463	CARDINAL
ajlm-2099	267	1	rasmussen n	PERSON
ajlm-2099	272	1	zhao z.	PERSON
ajlm-2099	272	2	two	CARDINAL
ajlm-2099	272	3	mpo	PERSON
ajlm-2099	272	4	pr3	PRODUCT
ajlm-2099	273	1	clin chim acta	ORG
ajlm-2099	274	1	2017;470:93–96	CARDINAL